Medical information Clinical review pending

Genetic Testing

RUNX1 Gene Platelet Disorder With Associated Myeloid Malignancy Genetic Test

Genetic test to identify RUNX1 gene mutations linked to platelet disorders and myeloid malignancies. Helps in diagnosis and treatment planning.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required, but a detailed clinical history and family history (pedigree chart if possible) are necessary. Discuss any medications you are taking with your doctor.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the RUNX1 Gene Platelet Disorder With Associated Myeloid Malignancy Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Unexplained bleeding or easy bruising.
✓Family history of platelet disorders.
✓Family history of myeloid malignancies (e.g., AML).
✓Suspected hereditary platelet disorder.
✓Evaluation for predisposition to myeloid malignancy.

In plain language

What this test helps you understand

Identifies genetic mutations in the RUNX1 gene associated with platelet disorders and an increased risk of myeloid malignancies like acute myeloid leukemia (AML). Provides information for diagnosis, prognosis, and personalized treatment strategies.

The RUNX1 Gene Platelet Disorder with Associated Myeloid Malignancy NGS Genetic DNA Test is a specialized diagnostic tool that examines genetic mutations in the RUNX1 gene. These mutations are linked to various hematological disorders, particularly those affecting platelet function and myeloid malignancies. Understanding these genetic factors is crucial for effective diagnosis and treatment. This test utilizes Next-Generation Sequencing (NGS) technology to provide comprehensive insights into the genetic makeup of an individual’s blood cells, specifically looking for changes in the RUNX1 gene. A clinical history of the patient is required prior to testing, and a genetic counseling session is recommended to create a family history chart (pedigree) if relevant.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required, but a detailed clinical history and family history (pedigree chart if possible) are necessary. Discuss any medications you are taking with your doctor.

SampleBlood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.

MethodologyNext-Generation Sequencing (NGS) of the RUNX1 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the RUNX1 gene. It does not detect mutations in other genes that might cause similar conditions. Results must be interpreted in the context of clinical findings and family history. Not all RUNX1 mutations are fully understood.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The RUNX1 gene provides instructions for making a protein that is important for the development of blood cells, particularly platelets and certain types of white blood cells.

This test helps identify specific genetic changes (mutations) in the RUNX1 gene that can cause platelet disorders and increase the risk of developing myeloid malignancies like leukemia.

Individuals with symptoms like unusual bleeding or bruising, or those with a family history of platelet disorders or myeloid malignancies, may be recommended for this test.

Results will indicate the presence or absence of specific RUNX1 gene mutations. A healthcare professional, like a hematologist or genetic counselor, will explain what the results mean for your health.

Based on the results and your clinical situation, your doctor will discuss potential management options, which may include monitoring, lifestyle changes, or specific treatments.

Yes, genetic counseling is recommended before the test to understand its implications and after receiving results to discuss their meaning and potential impact on you and your family.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp